Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Change in Cash (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Change in Cash for 6 consecutive years, with -$3.7 million as the latest value for Q4 2018.

  • Quarterly Change in Cash fell 43.85% to -$3.7 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Dec 2018, down 213.13% year-over-year, with the annual reading at -$693000.0 for FY2025, 84.5% up from the prior year.
  • Change in Cash hit -$3.7 million in Q4 2018 for Armata Pharmaceuticals, down from -$2.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $10.0 million in Q1 2015 to a low of -$3.9 million in Q1 2014.
  • Historically, Change in Cash has averaged -$851800.0 across 5 years, with a median of -$2.5 million in 2015.
  • Biggest five-year swings in Change in Cash: tumbled 2641.26% in 2014 and later surged 596.19% in 2017.
  • Year by year, Change in Cash stood at -$3.2 million in 2014, then rose by 26.15% to -$2.4 million in 2015, then soared by 173.68% to $1.7 million in 2016, then plummeted by 248.68% to -$2.6 million in 2017, then plummeted by 43.85% to -$3.7 million in 2018.
  • Business Quant data shows Change in Cash for ARMP at -$3.7 million in Q4 2018, -$2.0 million in Q3 2018, and $874000.0 in Q2 2018.